• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

Oral Systemic Treatment Options for a 28-Year-Old Woman With Moderate Atopic Dermatitis

The panelist discusses how a 28-year-old woman with moderate atopic dermatitis requires personalized, comprehensive management addressing hand involvement, corticosteroid concerns, and potential Janus kinase (JAK) inhibitor therapy, focusing on symptom relief, safety, and patient-specific factors.

Video content above is provided by the following:

  • Please provide your initial impressions of this case. Does the involvement of the patient’s hands influence your management plan at all?
  • How would you address the patient’s concerns regarding potential adverse effects of topical corticosteroids?
  • Describe your approach to treatment options for this patient. What patient-specific factors would you take into consideration when deciding on a treatment?
  • In what scenarios would a JAK inhibitor be preferred over another systemic agent?
  • How would decide between a topical or systemic JAK inhibitor for a patient?
  • What can the patient expect in terms of efficacy and safety with upadacitinib? When should she expect initial symptom relief?
Related Videos
1 expert in this video
1 expert is featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
© 2025 MJH Life Sciences

All rights reserved.